Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950123-09-063844
Filing Date
2009-11-18
Accepted
2009-11-18 13:43:51
Documents
2
Group Members
ANSBERT GADICKEDENNIS HENNERKURT WHEELERLUKE EVNINMICHAEL STEINMETZMPM ASSET MANAGEMENT INVESTORS 2005 BVIII LLCMPM BIOVENTURES III GMBH & CO BETEILIGUNGS KGMPM BIOVENTURES III GP LPMPM BIOVENTURES III LLCMPM BIOVENTURES III PARALLEL FUND LPMPM BIOVENTURE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D f54114sc13dza.htm SC 13D/A 280261
2 EX-99.C f54114exv99wc.htm EX-99.C 22403
  Complete submission text file 0000950123-09-063844.txt   305372
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40119 | Film No.: 091192961
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116
Business Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 5TH FLOOR BOSTON MA 02116 617 425 9200
MPM BIOVENTURES III LP (Filed by) CIK: 0001173408 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A